Long Island Vein Treatment doctors
 |
Channing R. Barnett, MD
New York Dermatologist
163A East 70th St., New York |
|
3 answers |
 |
Felix Kuo, MD
Long Island Dermatologist
775 Park Avenue Suite 145, Huntington |
3 answers | |
 |
Kari L. Colen, MD
New York Plastic Surgeon
742 Park Avenue, New York |
1 answer | |
 |
Ted Brezel, MD
New York Dermatologist
79-59 Myrtle Avenue, Glendale |
|
|
 |
Joshua L. Fox, MD
Long Island Dermatologic Surgeon
165 Roslyn Road, Roslyn Heights |
|
Recent Answers
I am a 24 yr old female with red Telangiectases superficial spider veins on my chest (a few on bridge of nose). I tanned regularly in university, burning a few times. I was on 100mg spironolactone for 2 mths, then went on accutane (20mg/day 120 lb) 5 mths (this worked for my acne), but the veins seem to be getting worse daily. I am very concerned given I am only 24. I am considering laser in a few months but want to understand the cause. I feel ugly, any suggestions or advice would be great.
Based on the photos which are somewhat blurry, it appears that you have a combination of redness (mostly related to the broken blood vessels) and brown discoloration. These are both likely secondary to sun damage, and are more common in fair-skinned individuals. A series of intense pulse light (IPL) treatments can help improve this with minimal downtime. Also very effective but requiring more healing would be a combination of the erbium laser to the brown spots and light electrodessication (superficial burning) to the broken blood vessels. The most important thing you can do at this point is to protect the areas from future sun damage by practicing sun safe habits.
i have spider veins and vascular lines on my legs. I've tried scleratherapy in the past but dont like the *shadowing*. Is Polidocanol better, can I get it in the US?
and the brand name is Asclera. Polidocanol along with STS are in the "detergent" class of sclerosing agents and considered the safest. The "shadowing" you mention may be post-inflammatory hyperpigmentation (PIH) which sometimes may take up to 1-2 months to resolve. It is also possible that the shadowing is from formation of grouped or matted telangiectasia near the treated vessel. Asclera can cause PIH but less commonly than STS. The rish of this temporary pigmentation can be further minimized by matching the vessel size with the right concentration. Asclera comes in two concentrations: 0.5% and 1.0% The risk of matted telangiectasia can also be minimized by rate of injection and volume of solution used.